Loss of function mutations in the X-linked gene encoding the methyl-CpG-binding protein 2 (MeCP2) involved in transcriptional silencing and activation and RNA splicing modulation is thought to contribute to the pathophysiology of RTT (199, 200). The gene discussed is MECP2; the disease is Rett syndrome.